Press Releases from APEPTICO Forschung und Entwicklung (1 total)
APEPTICO presents its lead product AP301 at the Annual Congress of the European …
08th September, 2009, Vienna, Austria: APEPTICO Forschung und Entwicklung GmbH, a biotechnology company developing a novel peptide-based drug for the treatment of the life threatening disease “Acute Lung Injury” today announced, that it will present its most recent scientific results for APEPTICO’s lead compound AP301 at the Annual Congress of the European Respiratory Society which starts on 12th September 2009 in Vienna, Austria.
At the Annual Congress of the European Respiratory…
